NO20065722L - Medisinske aerosolformuleringsprodukter med forbedret kjemisk stabilitet. - Google Patents

Medisinske aerosolformuleringsprodukter med forbedret kjemisk stabilitet.

Info

Publication number: NO20065722L
Authority: NO; Norway
Prior art keywords: aerosol formulation; chemical stability; improved chemical; linking agent; butyl rubber
Prior art date: 2004-05-13

Application number

NO20065722A

Other languages

English (en)

Norwegian (no)

Inventor

David Lewis

Brian John Meakin

Tanya Kathleen Church

Robert Johnson

Original Assignee

Chiesi Farma Spa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-05-13

Filing date

2006-12-12

Publication date

2006-12-12

2006-12-12 Application filed by Chiesi Farma Spa filed Critical Chiesi Farma Spa

2006-12-12 Publication of NO20065722L publication Critical patent/NO20065722L/no

Links

239000000443 aerosol Substances 0.000 title abstract 5
239000000203 mixture Substances 0.000 title abstract 4
238000009472 formulation Methods 0.000 title abstract 3
239000000126 substance Substances 0.000 title abstract 2
229920005549 butyl rubber Polymers 0.000 abstract 2
239000003431 cross linking reagent Substances 0.000 abstract 2
229940071648 metered dose inhaler Drugs 0.000 abstract 2
239000002253 acid Substances 0.000 abstract 1
239000004480 active ingredient Substances 0.000 abstract 1
SKOLWUPSYHWYAM-UHFFFAOYSA-N carbonodithioic O,S-acid Chemical class SC(S)=O SKOLWUPSYHWYAM-UHFFFAOYSA-N 0.000 abstract 1
150000001875 compounds Chemical class 0.000 abstract 1
239000006184 cosolvent Substances 0.000 abstract 1
229910052500 inorganic mineral Inorganic materials 0.000 abstract 1
229940127212 long-acting beta 2 agonist Drugs 0.000 abstract 1
239000011707 mineral Substances 0.000 abstract 1
229920001021 polysulfide Polymers 0.000 abstract 1
239000003380 propellant Substances 0.000 abstract 1
238000007789 sealing Methods 0.000 abstract 1
239000003381 stabilizer Substances 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4704—2-Quinolinones, e.g. carbostyril
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies

Landscapes

Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Bioinformatics & Cheminformatics (AREA)
Animal Behavior & Ethology (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Epidemiology (AREA)
Pulmonology (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Otolaryngology (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Cosmetics (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Containers And Packaging Bodies Having A Special Means To Remove Contents (AREA)

NO20065722A 2004-05-13 2006-12-12 Medisinske aerosolformuleringsprodukter med forbedret kjemisk stabilitet. NO20065722L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
EP04011425		2004-05-13
PCT/EP2005/002041 WO2005112902A2 (en)	2004-05-13	2005-02-25	Medicinal aerosol formulation products with improved chemical stability

Publications (1)

Publication Number	Publication Date
NO20065722L true NO20065722L (no)	2006-12-12

Family

ID=34960892

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20065722A NO20065722L (no)	2004-05-13	2006-12-12	Medisinske aerosolformuleringsprodukter med forbedret kjemisk stabilitet.

Country Status (19)

Country	Link
US (1)	US20070086953A1 (pt)
EP (1)	EP1746981B1 (pt)
JP (1)	JP2007537170A (pt)
KR (1)	KR20070010159A (pt)
CN (1)	CN1950075A (pt)
AT (1)	ATE404185T1 (pt)
AU (1)	AU2005245248A1 (pt)
BR (1)	BRPI0510852A (pt)
CA (1)	CA2565747A1 (pt)
DE (1)	DE602005008946D1 (pt)
EA (1)	EA200602112A1 (pt)
ES (1)	ES2309722T3 (pt)
IL (1)	IL178739A0 (pt)
MA (1)	MA28649B1 (pt)
MX (1)	MXPA06013189A (pt)
NO (1)	NO20065722L (pt)
TN (1)	TNSN06334A1 (pt)
WO (1)	WO2005112902A2 (pt)
ZA (1)	ZA200608742B (pt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GEAP201814192A (en) *	2013-12-30	2018-02-26	Chiesi Farm Spa	Stable pressurised aerosol solution composition of glycopyrronium bromide and formoterol combination
RS57687B1 (sr) *	2013-12-30	2018-11-30	Chiesi Farm Spa	Pod pritiskom stabilan aerosolni rastvor kompozicije glikopironijum bromida i kombinacije formoterola
CN106620976B (zh) *	2016-12-28	2020-01-07	四川普锐特医药科技有限责任公司	一种丙酸氟替卡松定量吸入气雾剂
GB202001537D0 (en)	2020-02-05	2020-03-18	Consort Medical Plc	Pressurised dispensing container
US20230277451A1 (en) *	2020-10-09	2023-09-07	Chiesi Farmaceutici S.P.A.	A pharmaceutical formulation for pressurised metered dose inhaler

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU2000250701B2 (en) *	2000-05-22	2004-07-01	Chiesi Farmaceutici S.P.A.	Stable pharmaceutical solution formulations for pressurised metered dose inhalers
US20060257324A1 (en) *	2000-05-22	2006-11-16	Chiesi Farmaceutici S.P.A.	Pharmaceutical solution formulations for pressurised metered dose inhalers
ES2342463T3 (es) *	2002-03-01	2010-07-07	Chiesi Farmaceutici S.P.A.	Formulacion superfina de formoterol.
US20040126325A1 (en) *	2002-03-12	2004-07-01	David Lewis	Medicinal aerosol solution formulation products with improved chemical stability
EP1485443B1 (en) *	2002-03-18	2007-01-03	Bespak Plc	Seal material for a dispensing apparatus
KR20070000476A (ko) *	2004-02-27	2007-01-02	키에시 파르마슈티시 엣스. 피. 에이.	압축화 계량된 도스흡입용 안정된 약제용액 제제
EP1595531A1 (en) *	2004-05-13	2005-11-16	CHIESI FARMACEUTICI S.p.A.	Stable pharmaceutical solution formulations for pressurized metered dose inhalers
EP1850831B1 (en) *	2005-02-25	2015-12-02	CHIESI FARMACEUTICI S.p.A.	Pharmaceutical aerosol formulations for pressurized metered dose inhalers comprising a sequestering agent

2005
- 2005-02-25 BR BRPI0510852-7A patent/BRPI0510852A/pt not_active IP Right Cessation
- 2005-02-25 JP JP2007511888A patent/JP2007537170A/ja active Pending
- 2005-02-25 ES ES05715569T patent/ES2309722T3/es not_active Expired - Lifetime
- 2005-02-25 WO PCT/EP2005/002041 patent/WO2005112902A2/en not_active Ceased
- 2005-02-25 CN CNA2005800147005A patent/CN1950075A/zh active Pending
- 2005-02-25 KR KR1020067022859A patent/KR20070010159A/ko not_active Withdrawn
- 2005-02-25 DE DE602005008946T patent/DE602005008946D1/de not_active Expired - Lifetime
- 2005-02-25 AU AU2005245248A patent/AU2005245248A1/en not_active Abandoned
- 2005-02-25 AT AT05715569T patent/ATE404185T1/de not_active IP Right Cessation
- 2005-02-25 CA CA002565747A patent/CA2565747A1/en not_active Abandoned
- 2005-02-25 MX MXPA06013189A patent/MXPA06013189A/es not_active Application Discontinuation
- 2005-02-25 EA EA200602112A patent/EA200602112A1/ru unknown
- 2005-02-25 EP EP05715569A patent/EP1746981B1/en not_active Expired - Lifetime
2006
- 2006-10-13 TN TNP2006000334A patent/TNSN06334A1/en unknown
- 2006-10-19 IL IL178739A patent/IL178739A0/en unknown
- 2006-10-19 ZA ZA200608742A patent/ZA200608742B/en unknown
- 2006-11-10 US US11/558,793 patent/US20070086953A1/en not_active Abandoned
- 2006-12-04 MA MA29511A patent/MA28649B1/fr unknown
- 2006-12-12 NO NO20065722A patent/NO20065722L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
MA28649B1 (fr)	2007-06-01
CA2565747A1 (en)	2005-12-01
ATE404185T1 (de)	2008-08-15
ES2309722T3 (es)	2008-12-16
EA200602112A1 (ru)	2007-04-27
AU2005245248A1 (en)	2005-12-01
EP1746981A2 (en)	2007-01-31
MXPA06013189A (es)	2007-02-14
WO2005112902A3 (en)	2006-05-04
IL178739A0 (en)	2007-02-11
DE602005008946D1 (de)	2008-09-25
TNSN06334A1 (en)	2008-02-22
US20070086953A1 (en)	2007-04-19
CN1950075A (zh)	2007-04-18
KR20070010159A (ko)	2007-01-22
JP2007537170A (ja)	2007-12-20
EP1746981B1 (en)	2008-08-13
WO2005112902A2 (en)	2005-12-01
ZA200608742B (en)	2008-07-30
BRPI0510852A (pt)	2007-11-27

Similar Documents

Publication	Publication Date	Title
AR130239A2 (es)	2024-11-20	Método para reducir la cantidad del producto de degradación dp3 durante la vida de estante de una composición farmacéutica en solución para aerosol y uso de una lata de aerosol asociada
ES2618829T3 (es)	2017-06-22	Sello para un aparato dispensador
DK0616525T3 (da)	1996-01-08	Medikamenter
DE60308997D1 (de)	2006-11-23	Formulierungen zur inhalation
NZ526564A (en)	2004-12-24	Metered dose inhaler for salmeterol xinafoate
AU2024219491B2 (en)	2026-03-12	Pressurised dispensing container
MY143075A (en)	2011-02-28	Stable pharmaceutical solution formulations for pressurized metered dose inhalers.
BR0208363A (pt)	2004-03-09	Produtos de formulação de solução aerossol medicinal com estabilidade quìmica melhorada
NO20065722L (no)	2006-12-12	Medisinske aerosolformuleringsprodukter med forbedret kjemisk stabilitet.
WO2005016410A3 (en)	2005-08-25	Pharmaceutical metered dose inhaler and methods relating thereto
EP1485443A1 (en)	2004-12-15	Seal material for a dispensing apparatus
WO2007020204A3 (en)	2007-06-07	Hfc solution formulations for inhalation containing salbutamol hydrochloride or salbutamol citrate
BR112012008983A2 (pt)	2016-04-05	"formulação medicinal em suspensão, composição farmacêutica, produto, uso de cromolina sódica,e, método para aumentar a estabilidade de uma formulação medicinal em suspensão de aerossol."
GB2410500A (en)	2005-08-03	Seal for a pharmaceutical dispensing device
WO2017021698A1 (en)	2017-02-09	Seal for a dispensing apparatus
BRPI0609029B1 (pt)	2018-02-14	Dispositivo de dispensação farmacêutica
BRPI0408003A (pt)	2006-02-14	produtos antiperspirante/desodorizante em aerossol
WO2004103339A3 (en)	2005-03-17	Improved metered dose inhaler
GB2415699A (en)	2006-01-04	Seal material for a dispensing apparatus
BR0012907A (pt)	2002-06-11	Agente para o remédio de dano neural, composto contendo nitrogênio, e, composição farmacêutica
GB2445483A (en)	2008-07-09	Seal for a pharmaceutical dispensing device
BRPI0405842B8 (pt)	2021-05-25	composição farmacêutica estabilizada de composto flúor-éter para uso anestésico. método para estabilizar um composto flúor-éter. uso de agente estabilizante para impedir a degradação de composto flúor éter.
BR112019005168A2 (pt)	2019-06-11	composição farmacêutica, recipiente vedado, inalador de dose medida, e, métodos para tratar um paciente que sofre ou susceptível de sofrer de um distúrbio respiratório, para melhoria da estabilidade de uma composição farmacêutica e do desempenho de aerossolização de uma composição farmacêutica e para reduzir o potencial de aquecimento global de uma composição farmacêutica
AR048418A1 (es)	2006-04-26	Formulaciones de soluciones medicinales estables para inhaladores de cartucho presurizados

Legal Events

Date	Code	Title	Description
2009-10-05	FC2A	Withdrawal, rejection or dismissal of laid open patent application